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Abstract 
Background  
Emergency gastrointestinal surgery (EGS) conditions represent a significant healthcare 
burden globally requiring emergency operations that are associated with mortality rates as 
high as 80%. EGS is currently focussed on quality improvement and internal audits, which 
occurs at a national or local level. An appreciation of what EGS trials are being conducted is 
important to reduce research wastage and develop coordinated research strategies in surgery. 
The primary aim of this study was to identify and quantify recent and active trials in 
emergency gastrointestinal surgery. The secondary aim was to identify conditions of interest, 
and which aspects of care were being modified. 
Methods  
A systematic search of WHO, UK, US, Australian and Canadian trials databases was 
undertaken using broad terms to identify studies addressing emergency abdominal surgery 
and specific high-risk diagnoses. Studies registered between 2013-2018 were eligible for 
inclusion. Data on study topic, design, and funding body were collected. Interventions were 
FODVVLILHG LQWR µSHUL-RSHUDWLYH¶ µSURFHGXUDO¶ µSRVW-RSHUDWLYH¶ µQRQ-VXUJLFDO¶ DQG µRWKHU¶
categories.  
Results  
Searches identified 5603 registered trials. After removal of duplicates, 4492 studies remained 
and 42 were eligible for inclusion. Almost 50% of trials were located in Europe and 17% 
(n=7) in the USA. The most common condition addressed was acute appendicitis (n=11), 
with the most common intervention being procedure based (n=23). Hospital based funding 
was the most common funder (n=30). 
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Conclusion 
There is large disparity in the number of surgical trials in emergency surgery, which are 
primarily focussed on high-volume conditions. More research is needed into high-mortality 
conditions.  
 
Evidence level: 1a (oxford) 
 
Keywords: Emergency surgery; randomised trials; research methodology 
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Background 
Emergency general surgery (EGS) conditions represent a significant healthcare burden 
globally1. Many of these conditions require emergency operations, with associated mortality 
rates ranging from 1.1% at 24 hours to 8.6% at 30 days. Even in high income countries such 
as the UK where high risk emergency surgical procedures account for 12.5% of total 
operations, death rates are as high as 80% 1,2. In addition, routine procedures in emergency 
surgery such as small bowel resection are associated with high morbidity rates which has 
further implications for patient recovery and healthcare costs 1-3.  
 
EGS activity is currently focussed on quality improvement and audits at a local or national 
level. These include the National Emergency Laparotomy Audit (NELA) in the UK and the 
National Surgical Quality Improvement Partnership (NSQIP) in the US 2,4. Quality 
improvement relies on a high-quality evidence base to guide efforts that are primarily 
designed to improve patient outcomes. It is recognised that EGS lacks a high quality evidence 
base 5 which may account for why many aspects of surgical practice are based upon dogma 6.  
 
To generate high-quality evidence to improve patient outcomes, it is necessary to conduct 
randomised clinical trials. The conduct of a clinical trial can take many years as funding and 
governance approvals must be secured, along with delivery of the study and analysis of 
findings. This means that there can be a significant period between the registration of a trial 
and the publication of findings. Knowing which trials are in progress is important to reduce 
research wastage and develop coordinated research strategies in surgery. It is considered 
standard practice for clinical trials to be registered on a database. This helps to prevent 
duplication and may also protect against publication bias. 
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The primary aim of this study was to identify and quantify recent and active trials in EGS. 
The secondary aim was to categorise research according to geographic base, funding body, 
condition of interest and intervention being trialled to grasp a better idea of what evidence-
based research in emergency surgery is currently being undertaken. 
 
Methods 
This study was conducted with reference to the Cochrane handbook and is reported with in 
line with the applicable fields of the PRISMA guidelines 7,8.    
 
Search strategy 
Information on emergency surgery trials was sourced from the UK Clinical Trials 9, UK 
Research and Innovation (UKRI)10, US Clinical trials 11, Australian New Zealand Clinical 
Trials Registry (ANZCTR) 12, World Health Organisation International Clinical Trials 
Registry Platform (ICTRP) 13, and Canadian International Standard Registered Clinical 
sTudy Number (ISRCTN) 14, databases online.  
 
To provide an accurate picture of current clinical trials underway in emergency surgery, 
search limitations were set to addressing any study registered or actively recruiting between 
January 2013 to January 2018. Searches were conducted of each database using a selection of 
terms with broad reference to EGS and specific high-risk diagnoses 15. These include 
³(PHUJHQF\6XUJHU\´25³$SSHQGLFLWLV´25³'LYHUWLFXOLWLV´25³%RZHO2EVWUXFWLRQ´25
³3DQFUHDWLWLV´25³&KROHF\VWLWLV´25³3HULWRQLWLV´25µ/DSDURWRP\´25³$FXWHDEGRPHQ´
25³'LYHUWLFXOLWLV´ZLWKRXWODQJXDJHUHVWULFWLRQV 
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Inclusion & Exclusion Criteria 
Emergency general surgery trials were defined as randomised controlled trials investigating 
non-elective and unplanned surgery of the GI tract. These included procedures from the 
upper oesophageal sphincter to anus, abdominal wall disease and liver disease.  Studies 
addressing vascular, neurological, gynaecological, thoracic surgical emergencies and 
pharmacological testing were excluded, as were those registered before 2013 or not currently 
active during the relevant period.  
 
Study Selection 
Searches were conducted by one researcher. The title and abstract of each remaining database 
results were independently assessed by both researchers to confirm eligibility. Where there 
was a disagreement over eligibility, the abstract was discussed by researchers to reach an 
agreement.  
 
Data extraction 
Information regarding trial name, start date, sponsor, funding body and location of study, was 
tabulated on an excel spreadsheet. Multicentre trials were localised according to their primary 
clinical unit (the location of the chief investigator). Interventions were assigned into one of 
five categories ³3URFHGXUDO´LHIRFXVVLQJRQDVSHFLILFSURFHGXUHRUDVSHFWRIDSURFHGXUH
during surgery including comparing surgical interventions to medical interventions ³1RQ-
surgical´ LH QRW testing D VXUJLFDO LQWHUYHQWLRQ ³3HULRSHUDWLYH´ LH WKRVH LQWHUYHQWions 
taking place in theatre), ³3RVWRSHUDWLYH´ LH WKRVH LQWHUYHQWLRQV WDNLQJ SODFH IROORZLQJ
surgery) DQG³2WKHU´QRQHRIWKHDERYH. Categories of funding source were defined in line 
with internationally selected guidelines 16.  As this is a systematic analysis of trials concerned 
with overview of current activity, no quality or bias assessment was performed.  
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Results 
Search results 
The research identified 5603 trials from initial screening. Following removal of duplicates, 
4492 unique records were identified (figure 1).  These underwent dual screening and 48 
records were identified. Those excluded did not meet the inclusion criteria, being identified 
from broad search terms. After full review of their registration, 6 were removed for the 
following reasons; Not active or registered within the selected time period, (SCARELESS, 
CReST and LEONARDO; n=3), Observational study (STELLA; n=1), preventative or 
diagnostic procedure, (Prophylaxis of post-ERCP pancreatitis using temporary pancreatic 
stent vs rectal nonsteroidal anti-inflammatory drug and the use of different sized USS guided 
needles in the diagnosis of acute appendicitis; n=2). 
 
In total 42 trials were identified. Fourteen were identified from ICTRP, 11 from the US 
clinical trials database, 10 from UK clinical trials, three from the ANZCTR and ISRCTN 
respectively, and one from UKRI (see Table, Supplemental Digital Content 1, 
http://links.lww.com/TA/B231). These addressed Emergency surgery (n=9), Cholecystitis 
(n=6), Pancreatitis (n=3), Laparotomy (n=5), Appendicitis (n=11), Bowel Obstruction (n=2), 
Acute Abdomen (n=1) and Diverticulitis (n=5). A summary list of trials identified is 
presented in table 1.  
 
Timing and Type of Intervention 
Over 50% (n=23) studies were found to be investigating a procedure within the operating 
theatre, for example using different techniques or different equipment. Nine studies 
investigated non-surgical management, such as using antibiotics to treat appendicitis 
followed by a delayed appendicectomy or the use of gastrografin for bowel obstruction. Six 
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Figure  SEQ Figure \* ARABIC 3: Global distribution of trials 
studies were focussed on addressing peri-operative factors, for example the use of IV fluids 
during operating to improve outcomes or the insertion of rectus sheath blocks at the end of 
surgery to improve post-operative pain intensity. Three of the studies were focussed on post-
operative outcomes mainly looking at physiotherapy and quality improvement in post-
operative care. 7ZRVWXGLHVZHUHFODVVLILHGDV³RWKHU´IRFXVVLQJRQWKHXVHRIWHOHPHGLFLQHLQ
the remote management of damage control surgery and the use of a smart phone in assessing 
surgical site infections. Graphical representation of intervention categories is highlighted in 
figure 2.  
 
Funding source  
Hospital based funding was the most common funding category accounting for 30 trials. The 
category named affiliated medical research bodies was the second most common funding 
category with eight trials. These included the NIHR (National institute of health research), 
the UK MRC (medical research council), Canadian forces medical services, Hungarian 
pancreatic study group and Southwest oncology group. Private sponsors (n=3) are 
individually named sponsors. Commercially based sponsors included Bupa, a private health 
insurance company.  
 
Emergency surgery 
Nine studies addressed emergency surgery in general. Three of these trials focused on EGS 
procedures, such as laparoscopic versus open surgery (LaCeS), using nanotechnologies as a 
fixing method for prosthetic materials in emergency laparoscopic procedures and the role of 
endoluminal stenting in the acute management of obstructing colorectal cancer. Two trials 
were categorised as peri-operative management, investigating Fluid optimisation in 
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emergency laparotomy (FLO-ELA) and comparing direct and guide wire assisted techniques 
to artery cannulation in patients posted for emergency surgery and the association between 
oxygen saturations and post-operative cognitive dysfunction in the elderly undergoing EGS. 
The single post-operative trial investigated the outcomes of enhanced rehabilitation in 
patients following EGS. One trial was categorised DV³RWKHU´LQYHVWLJDWLQJZKHWKHUWKHXVHRI
a smart phone tool aided the earlier identification and management of surgical site infections 
in EGS patients. Four of the studies were carried out in the UK, one in China, France, India, 
Italy and Tasmania respectively. Five studies received hospital funding, three were funded by 
affiliated medical research bodies. The remaining study was privately funded. 
 
Laparotomy  
Five studies investigating laparotomy were identified. Two studies were categorised as 
procedural, investigating the outcomes of damage control surgery and comparing 
endoscopically assisted colostomy with Colopexy to Laparotomy (EACC). Two other trials 
were FDWHJRULVHGDV³SHUL-RSHUDWLYH´, one was based in the UK looking at interventions for 
quality improvement for patients undergoing emergency laparotomy (EPOCH) and the other 
was based in Dubai investigating the post-surgical use of rectal sheath blocks for pain 
management. 2QH WULDODGGUHVVLQJ ODSDURWRP\ZDVFDWHJRULVHGDV³RWKHU´ LQYHVWLJDWLQJ WKH
use of telemedicine to mentor surgeons in damage control surgery for critically injured 
trauma patients from afar. This trial took place in Canada and was funded by the Canadian 
armed forces. One trial (EPOCH) was funded by the National Institute of Health Research 
(NIHR), two trials were received hospital-based funding and one trial was privately funded in 
Dubai. 
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Appendicitis 
Eleven trials addressing acute appendicitis were identified. Six trials were categorised as 
³QRQ-VXUJLFDO´DQG investigated the outcomes of antibiotics for the treatment of appendicitis 
when compared to surgery. Notably, four of these trials (CONTRACT; APPY; COMMA and 
CHINA), were focused exclusively on paediatric populations. Four trials investigated 
procedural techniques for appendicectomy. This included the use of Polymer clips versus 
endoloops (PECAS), Clips vs staples, the use of single versus multiple ports, and an interval 
appendicectomy post antibiotic therapy for acute appendicitis (CHINA). Four (36%) of the 
trials originated from the USA, three in the UK, one in Taiwan and the remaining three in 
Europe (see Figure, Supplemental Digital Content 2, http://links.lww.com/TA/B232). The 
majority (n=8) of trials identified from the search term appendicitis received hospital-based 
funding. 
 
Cholecystitis  
Six EGS trials addressed cholecystitis. Five (83%) of which focussed on EGS procedures, 
including intra-operative ERCP vs laparoscopic bile duct exploration for bile duct clearance 
in patients undergoing emergency cholecystitis, immediate vs delayed laparoscopic 
cholecystectomy in two trials, laparoscopic vs conservative treatment in acute cholecystitis, 
and intra-gallbladder or systemic Indocyanide green injection to facilitate cholecystectomy in 
patients with acute cholecystitis. One study investigated the use of extended antibiotic 
therapy post-operatively in reducing infections. Five (83%) of the studies were hospital 
funded, one was privately funded. All six of the trials were carried out in different countries 
including: Australia, Argentina, Finland, Japan, Taiwan and Saudi Arabia. 
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Bowel obstruction 
Two studies addressing bowel obstruction were identified. The first study investigated the 
non-surgical use of water soluble contrast in addition to medical management for malignant 
bowel obstruction in adults. This study was performed in Australia and received hospital-
based funding. The second procedure-based study compared outcomes associated with 
conservative or surgical management of malignant bowel obstruction. This was funded by 
Southwest Oncology Group and was carried out Canada.  
 
Diverticulitis 
Five studies addressing diverticulitis were identified. Four (80%) of the studies were 
procedure based EGS trials comparing laparoscopic lavage vs primary resection of an area of 
the colon in the treatment of acute diverticulitis. The remaining trial addressing diverticulitis 
was categorised as non-surgical investigating the rate of surgical site infection using vacuum 
assisted therapy in emergent contaminated abdominal surgery. One of the trials was being 
undertaken in the USA, the remaining three within Europe. All five (100%) of the trials were 
funded by hospital-based funding. 
 
Acute pancreatitis 
Three studies addressed pancreatitis. All three were categorised as µSURFHGXUDO¶ RQH VWXG\
investigated the use of stents for acute necrotizing pancreatitis, one compared the use of a 
stent vs no stent in acute pancreatitis and the other investigated the optimal time for 
cholecystectomy in acute biliary pancreatitis. One study was carried out in a US hospital 
where the funding originated. The second study took place in Hungary and was funded by the 
Hungarian pancreatic study group. The third study was undertaken in Egypt and was funded 
by the local hospital. 
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Figure  SEQ Figure \* ARABIC 2:Timing of intervention 
Acute Abdomen 
One study addressing acute abdomen was identified (CLIPPER2). This trial compared the 
related morbidity rates of two different procedures; surgical versus endoscopic closure in 
patients with acute colonic perforations. The study took place in Germany and received local 
hospital-based funding. 
 
Discussion 
This study identified 42 EGS trials with activity in the last 5 years. We found that the 
majority of recent trials within emergency surgery are addressing low mortality conditions 
such as appendicitis (n=11), not those with high mortality rates such as emergency 
laparotomy (n=5) 17. Although initial searches gathered nearly 4000 studies, on reviewal by 
the research team the majority of studies were not research in emergency surgery, merely 
being identified within the database because of the search term used. Across all settings 
funding was typically secured at a local level (n= 30), and eleven trials (26%) had cohorts 
less than 100 participants. Studies with smaller sample sizes, either due to a lack of funding 
or challenges in recruitment may hinder the progression of the EGS evidence base and 
perhaps only offering marginal gains 18.  
 
In general, surgical trials are aimed at either improving long term outcomes, or perioperative 
morbidity in the elective setting, despite there being a lower risk of morbidity and mortality 
than seen in the EGS population. When comparing the population affected by emergency 
surgical conditions, and the evidence base to support interventions to the number affected and 
volume-based research within elective surgery there is a large disparity. Our evidence is 
supported by Morley et al 19 which identified between 2010 and 2012 only 39 out of 414 
trials addressing surgery were aimed at emergency surgery. Their study showed that both 
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emergency and elective study trials had equal risks of being terminated early and were 
equally likely to be published once registered. This implies that EGS research has equal 
opportunities for success as that in elective settings, and more must to be done to bridge the 
gap in research. This study did not undertake formal comparison of the number of EGS trials 
to another clinical area as the research team could not select a suitable comparator population 
or condition. 
 
Searches within each database showed that several EGS related studies were registered in the 
study period. Many did not meet the inclusion criteria because there were either observational 
studies or case series with very few participants 20. Observational studies have an important 
role in informing surgical practice including describing epidemiology, outcomes and 
identifying potential areas for intervention. However, observational studies are poorly suited 
to attributing causation and testing solutions without considerable risk of selection bias. 
Trials in the emergency setting are challenging to conduct as emergency care is often 
delivered when time and resources are pressured 21. There are potential challenges in 
identifying and recruiting patients, alongside implementing interventions in a timely and 
standardised manner. These practical issues require further research. Nevertheless, 
conducting surgical trials in this setting is possible, as is done routinely in intensive care 
medicine and in emergency medicine 22.  
 
There are numerous challenges in the delivery of EGS trials. Firstly, the population of high-
risk emergency surgical patients is highly heterogenous. These patients often have complex 
multi-system disease and uncertain diagnoses which may only be identified intraoperatively 
or even postoperatively. This represents a challenge in the recruitment and delivery of 
interventions. Secondly, this patient group is often critically unwell, and clinical delay due to 
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research may present barriers to recruitment. In addition, there is variation in practice and 
scope of EGS and constituent teams globally, which could contribute to the difficulty in 
enrolling patients in areas less well supported. There are however, some factors which should 
improve the feasibility of EGS trials. Emergency general surgery conditions are also 
common, meaning that a large population is available to participate in trial. Morbidity and 
mortality in this group are common, and often occur close to the index event of surgery 23 
potentially meaning  shorter-term follow-up are necessary to assess outcomes. 
 
Our study identified very few EGS trials outside of high income settings with clinically 
significant sample sizes. Populations in low and middle-income settings have a higher 
requirement for emergency surgical services and poorer outcomes than high income 
populations 24. However, in our study, the studies we identified within low-middle income 
countries had very few participants. Four out of the nine studies identified with fewer than 
100 participants were carried out in low-middle income countries (EACC, Single-incision 
laparoscopic surgery in acute abdomen, Acute biliary pancreatitis - optimal time for 
cholecystectomy, and The onset time of rocuronium in emergency and elective surgery). 
These settings present unique challenges and may be where the greatest gains in outcome 
may be. Identifying interventions which are effective in improving outcomes from 
emergency surgery across the world would enable a far larger population to benefit. There are 
multiple reasons why surgical trials may not have been identified in these settings. First, 
these countries may not have requirements to register clinical trials prospectively and hence 
would not have been identified by our searches. This is unlikely as we searched multiple 
international databases and the requirement for prospective registration is common. 
Secondly, resource and ethical limitations may play a role. Clinicians in these settings are 
more stretched, dedicating most of their time to service provision, leaving very limited time 
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for participant recruitment or data collection. Moreover, they may lack the necessary 
resources to undertake research. International initiatives are aiming to change this, with 
capacity building networks being formed in surgery, such as the GlobalSurg collaborative 25, 
who have just launched a factorial randomised trial investigating skin preparation. 
 
This study is not without limitations. Whilst it is expected that all trials are registered 
following the legislation implemented by the International Committee of medical Journal 
Editors in 2005 26, it is possible that some may not be identified through the searches. We did 
not search for resulting publications and were unable to account for unpublished research, nor 
research that remains within the hospital or country where it was carried out, meaning it is 
available globally. This could be resolved by streamlining the regulation process, making all 
studies from the various databases available on one global database with unlimited 
international access. This would also make it simpler for authors to both recruit and register 
trials globally. However, a recent study suggests that 46% of EGS trials are published 19. We 
recognise that the findings of our study may age, if significant changes are made to 
encourage future emergency surgery research, however it will provide a useful benchmark 
progress in this field. The strengths of this study include adherence to methodological 
principles, dual review of candidate studies, and interrogation of multiple databases using 
multiple search terms, meaning the majority of candidate studies should have been identified. 
This allows a robust estimate of international trial activity in EGS. 
 
For elective surgery, time for preoperative optimisation and careful planning provide a 
controlled environment to undertake research aimed at improving surgical and perioperative 
outcomes. This is not a luxury afforded to research in the emergency setting. Nevertheless, 
this study highlights that there is a large disparity in the number of randomised trials in 
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elective versus emergency surgery that are currently being performed. It is imperative that 
this gap is addressed to improve both the quantity and quality of the literature in this field, 
which is key for improving EGS outcomes.  Future studies should focus on high-risk groups 
(i.e. emergency laparotomy), in addition to high-volume groups (i.e. appendicitis) for 
maximal benefit. Researcher teams should include the wider surgical team, anaesthetists, 
intensivist, emergency physicians and methodologists. Teams should work to optimise trial 
designs in order to answer important research questions robustly, while adequately 
addressing the complex challenges to research in the emergency setting 27. 
 
One way to improve outcomes in emergency surgeries, is by making funding more 
accessible. It was notable in this review that many of the studies were supported by local 
hospital funds, rather than national level funders such as the National Institute for Health 
Research (NIHR) in the UK, or the National Institute for Health (NIH) in the use. These 
strategic funding bodies could consider commissioned calls for EGS projects, and 
incentivisation of units to deliver emergency surgery research. This may help to increase the 
number of trials that are addressing high morbidity conditions such as laparotomy and bowel 
obstruction.  
 
There is large disparity in the number of surgical trials in emergency surgery, which are 
primarily focussed on high-volume conditions. More research is needed into high-mortality 
conditions. Future efforts should focus on improving both the quantity and quality of research 
in these patients and ensuring findings are generalisable for patients across the world. 
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Figure legends 
 
Figure 1: PRISMA Flow Diagram 
 
Figure 2: Intervention categories in EGS trials  
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Figure 1 
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Figure 2 
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Tables 
 
Table 1: Summary of included studies 
 
Search Term Acronym Summary of trial details 
Timing/ Type 
of 
intervention 
Primary 
Outcomes 
E
m
e
rg
e
n
cy
 S
u
rg
e
ry
 
FLO-ELA 
The use of intravenous fluids 
post-operatively to improve 
recovery 
Peri-
operative 
Recovery 
time 
LACES Laparoscopic vs open surgery 
Procedure 
based 
30 day 
mortality 
rates 
ICE AGE 
Complication rates following 
emergency abdominal surgery 
Post-
operative 
Complication 
rates 
NA* 
Reducing wound infections 
after emergency surgery in low-
middle income countries >D/^͛Ɛ 
Post-
operative 
Time until 
wound 
infection 
NA* 
Colonic Stenting in Elective 
Surgery Versus Emergency 
Surgery in the Management of 
Acute Malignant Colonic 
Obstruction 
Peri-
operative 
Rates of 
primary 
colorectal 
anastomosis 
 
TWIST 
The use of a smartphone to 
assess surgical site infections. 
Non-
operative 
Time from 
surgery to 
treatment for 
surgical site 
infection 
Outcome 
assessed at 
30 day 
follow-up 
NA* 
Nanotechnologies Applied to 
General Surgery and Emergency 
Surgery: Buckypaper as a New 
Fixing Method for Prosthetic 
Materials 
Procedural 
Time of 
durability 
without side 
effects of 
surgical 
device 
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NA* 
Direct or guide-wire assisted 
techniques of radial artery 
cannulation in patients posted 
for emergency surgery. 
Procedure 
To compare 
success rate 
of 
cannulation 
on first 
attempt 
between the 
two 
techniques 
NA* 
The Association Between 
Variation in Oxygen Saturation 
(ScO2) and Incidence of 
Postoperative Cognitive 
Dysfunction (POCD) in a 
Population of Elderly Patients 
Admitted for Emergency 
Surgery. 
Post-
operative 
Occurrence 
of POCD 
 
C
h
o
le
cy
st
it
is
 
NA* 
Endoscopic 
Retrogradepancreatography 
versus laparoscopic common 
bile duct exploration for 
emergency cholecystitis 
Procedure 
Time of 
procedure 
NA* 
Extended Antibiotic Therapy in 
Postoperative of Laparoscopic 
Cholecystectomy in Acute 
Cholecystitis 
Post-
operative 
Incidence of 
infectious 
postoperative 
complications 
 
NA* 
Acute Cholecystitis: Early 
Versus Delayed Laparoscopic 
Cholecystectomy 
Peri-
operative 
Operative 
time 
 
NA* 
Laparoscopic Cholecystectomy 
or Conservative Treatment in 
the Acute Cholecystitis of 
Elderly Patients 
Post-
operative 
Specific 
Morbidity 
Index Scores 
 
NA* 
Early versus early interval 
laparoscopic cholecystectomy 
for acute cholecystitis 
Procedure 
Operation 
time 
NA* 
Intra-gallbladder or Systemic 
Indocyanide Green Injection 
Facilitate Cholecystectomy 
Post-
operative 
CBD 
identification 
(white light 
and infrared 
fluroscence 
image) 
P
a
n
cr
e
a
ti
ti
s NA* 
Stent vs no stent in necrotising 
pancreatitis preventing walled 
off necrosis 
Procedure 
Mortality 
rates 
NA* Early cholecystectomy was Procedure Gallstone 
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done within 48 after admission 
vs delayed done after 30 days 
after randomization 
related 
complications 
NA* 
Preventive pancreatic stents in 
the management of acute 
biliary pancreatitis 
Procedure 
Mortality and 
morbidity at 
30 days 
 
La
p
a
ro
to
m
y
 
NA* 
The use of telemedicine in off 
site management of emergency 
surgery 
Perioperative 
Safety and 
Feasibility of 
telemedicine 
NA* 
Incomplete vs complete closure 
in emergency laparotomy 
Procedure 
major 
abdominal 
complications 
and mortality 
rates 
EACC 
Endoscopically Assisted 
Colostomy With Colopexy for 
Critically Ill Patients Without 
General Anesthesia 
or Laparotomy (EACC) 
Procedure 
Safety and 
Tolerability of 
the 
procedure 
NA* 
Ultrasound guided rectus 
sheath block by the end of the 
surgery vs multiholed catheter 
for pain management 
Peri-
operative 
Self reported 
pain intensity 
EPOCH 
Quality improvement 
intervention for patients 
undergoing emergency 
laparotomy 
Post-
operative 
All cause 
mortality at 
90 days 
following 
surgery 
 
A
p
p
e
n
d
ic
it
is
 
CONTRACT 
Interval appendicectomy 
outcomes in children compared 
to normal appendicectomy 
Procedure 
Complication 
rates 
CHINA 
The childrens interval 
appendicetomy study 
Per-
operative 
Complication 
rates 
COMMA 
Polymer clips vs endoloops for 
closure of the appendiceal 
stump during emergency 
laparoscopic appendicectomy 
Procedure 
Time until 
next surgery 
PECAS 
Polymer Clips Versus Endoloops 
for Closure of the Appendiceal 
Stump During Emergency 
Laparoscopic Appendicectomy 
Procedure 
Complication 
rates 
APPY 
Appendectomy Versus Non-
Operative Treatment For Acute 
Non-Perforated Appendicitis in 
Children 
Non surgical 
Complication 
rates 
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APPAC 
Open Appendicectomy Versus 
Antibiotic Treatment 
(Ertapenem) in the Treatment 
of Acute Uncomplicated 
Appendicitis 
Non surgical 
Recurrence 
rates 
NA* 
Quality improvement 
intervention for patients 
undergoing emergency 
laparotomy 
Non surgical 
Quality 
improvement 
NA* 
Comparative Study of 
Polymetric Clips (Hem-o-Lok) 
Versus Historical Endoscopic 
Staplers for Laparoscopic 
Appendectomy 
Procedure 
Time for 
procedure 
NA* Single port vs multiport Procedural 
Post-
operative 
pain 
NA* 
Patient anxiety levels on the 
onset time of rocuronium in 
terms of anxiety scores 
Peri-
operative 
Anxiety score 
NA* 
Comparison of Medical and 
Surgical Treatment of 
Uncomplicated Acute 
Appendicitis in Children 
 
Non surgical 
Complication 
rates 
B
o
w
e
l 
O
b
st
ru
ct
io
n
 
NA* 
The use of gastrograffin in the 
treatment of bowel obstruction 
in addition to conservative 
management 
Non-
operative 
Mortality 
rates 
NA* 
Comparative Effectiveness Trial 
for Malignant Bowel 
Obstruction, surgery vs non 
surgery 
Procedure 
Number of 
days alive 
and outside 
the hospital 
D
iv
e
rt
ic
u
li
ti
s 
SCANDIV 
Laparoscopic Peritoneal Lavage 
or Resection for Generalised 
Peritonitis for Perforated 
Diverticulitis 
Procedure 
Time until re-
admission 
NA* 
Vacuum Assisted Therapy in 
Emergent Contaminated 
Abdominal Surgeries 
Procedure 
Post-
operative 
complication 
rates 
 
DILALA 
Diverticulitis - laparoscopic 
lavage versus resection 
(Hartman procedure) for acute 
diverticulitis with peritonitis 
Procedure 
Post-
operative 
complications 
LADIES Laparoscopic lavage vs primary Procedure Post-
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resection in management of 
acute diverticulitis 
operative 
complications 
LapLAV 
Laparoscopic lavage vs sigmoid 
resection in management of 
acute diverticulitis 
Procedure 
Post-
operative 
complications 
A
cu
te
 A
b
d
o
m
e
n
 
CLIPPER2 
Endoscopic versus surgical 
closure of acute colonic 
perforations 
Procedure 
Closure-
related 
morbidity, 
within 30 
days after the 
closure 
procedure 
 
NA*= not applicable  
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Table 1: Number of trials by database 
 
 
Database Number of Trials 
ICTRP 13 
UK Clinical Trials 10 
US Clinical Trial 4 
ANZCTR 3 
ISRCTN   2 
Gateway to Research UK 1 
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